Filter by Category: SENTRY Surveillance

Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: Report from the 2007-2009 SENTRY Antimicrobial Surveillance Program.

Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: Report from the 2007-2009 SENTRY Antimicrobial Surveillance Program. by Kaiser RM, Castanheira M, Jones RN, Tenover F and Lynfield R published in Diagn. Microbiol. Infect. Dis. 2013; 76 (3): 356-360

Prevalence of ß-lactamase encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 USA hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010).

Prevalence of ß-lactamase encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 USA hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010). by Castanheira M, Farrell SE, Deshpande LM, Mendes RE and Jones RN published in Antimicrob. Agents Chemother. 2013; 57 (7): 3012-3020

Contemporary potencies of minocycline and tetracycline HCL tested against gram-positive pathogens: SENTRY Program results using CLSI and EUCAST breakpoint criteria.

Contemporary potencies of minocycline and tetracycline HCL tested against gram-positive pathogens: SENTRY Program results using CLSI and EUCAST breakpoint criteria. by Jones RN, Wilson ML, Weinstein MP, Stilwell MG and Mendes RE published in Diagn. Microbiol. Infect. Dis. 2013; 75 (4): 402-405

Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: Report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).

Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: Report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011). by Jones RN, Sader HS, Mendes RE and Flamm RK published in Diagn. Microbiol. Infect. Dis. 2013; 75 (1): 107-109

Update of dalbavancin spectrum and potency in the USA; Report from the SENTRY Antimicrobial Surveillance Program (2011).

Update of dalbavancin spectrum and potency in the USA; Report from the SENTRY Antimicrobial Surveillance Program (2011). by Jones RN, Sader HS and Flamm RK published in Diagn. Microbiol. Infect. Dis. 2013; 75 (3): 304-307

Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).

Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: Results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). by Gales AC, Castanheira M, Jones RN and Sader HS published in Diagn. Microbiol. Infect. Dis. 2012; 73 (4): 354-360

Expansion of clonal complex 258 KPC-2-producing Klebsiella pneumoniae in Latin American hospitals: Report of the SENTRY antimicrobial surveillance program.

Expansion of clonal complex 258 KPC-2-producing Klebsiella pneumoniae in Latin American hospitals: Report of the SENTRY antimicrobial surveillance program. by Castanheira M, Costello AJ, Deshpande LM and Jones RN published in Antimicrob. Agents Chemother. 2012; 56 (3): 1668-1669

Comparative activity of linezolid against respiratory tract infection isolates of Staphylococcus aureus: An 11 year report from the SENTRY Antimicrobial Surveillance Program.

Comparative activity of linezolid against respiratory tract infection isolates of Staphylococcus aureus: An 11 year report from the SENTRY Antimicrobial Surveillance Program. by Jones RN, Farrell DJ, Sader HS published in Int. J. Antimicrob. Agents 2011; 37 (6): 580-587

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: Report from the SENTRY Antimicrobial Surveillance Programme (2007-09).

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: Report from the SENTRY Antimicrobial Surveillance Programme (2007-09). by Castanheira M, Mendes RE, Woosley LN and Jones RN published in J. Antimicrob. Chemother. 2011; 66 (6): 1409-1411

Susceptibility of Klebsiella spp. to colistin and polymyxin B: Results from the SENTRY Antimicrobial Surveillance Program (2006-2009).

Susceptibility of Klebsiella spp. to colistin and polymyxin B: Results from the SENTRY Antimicrobial Surveillance Program (2006-2009). by Sader HS, Farrell DJ and Jones RN published in Int. J. Antimicrob. Agents. 2011; 37 (2): 174-175